| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.0013 | 1 |